相关实验视频

Updated: Jun 18, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

瘤透淋巴细胞治疗临床试验的现状和前景

Yunting Zhang¹, Hongye Fu¹, Qiong Zhao²

¹Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

|July 30, 2024

概括

瘤透淋巴细胞 (TIL) 疗法是一种采用细胞疗法,对固体瘤有希望. 研究重点是提高TIL生存率,降低毒性,并确定更广泛的临床用途的预后标志物.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

免疫检查点抑制剂 (ICI) 已经在癌症治疗中取得了进展,但也有局限性.
瘤透淋巴细胞 (TIL) 疗法为固体瘤提供了一种新的方法.
对Lifileucel的商业批准意味着TIL治疗的一个里程碑.

研究的目的:

审查TIL治疗目前的临床试验格局.
概述TIL治疗的未来研究方向.
探索TIL治疗扩大临床应用的潜力.

主要方法:

审查涉及TIL治疗的当前临床试验.
分析TIL疗法的研究趋势和挑战.
对预后标记和治疗优化进行讨论.

主要成果:

TIL疗法是固体瘤的有效采用细胞疗法.
Lifileucel的批准标志着TIL商业化取得了重大进展.
目前的研究趋势旨在改善TIL的疗效和患者的治疗结果.

结论:

TIL疗法代表了癌症免疫疗法的有前途的进步.
未来的研究应该优先提高体内TIL生存率,并尽量减少毒性.
识别预后标志物对于优化TIL治疗和扩大其临床效用至关重要.

关键词:

临床试验临床试验是指临床试验的临床试验.免疫治疗是一种免疫疗法.黑色素瘤是一种黑色素瘤.瘤透的淋巴细胞透到瘤中.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...